Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-23-013280

Options or other derivatives

  • CFO, Treasurer & Secretary acquired 160,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Moss David J CFO, Treasurer & Secretary 2023-02-16 Grant or award · Option (right to buy) +160,000 160,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…